Research ExplorerPublicationsThe impact of 68Ga-DOTATOC positron emission tomography/comp...

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors

Standard

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. / Frilling, Andrea; Sotiropoulos, Georgios C; Radtke, Arnold; Malago, Massimo; Bockisch, Andreas; Kuehl, Hilmar; Li, Jun; Broelsch, Christoph E.

In: ANN SURG, Vol. 252, No. 5, 5, 11.2010, p. 850-856.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Frilling, A, Sotiropoulos, GC, Radtke, A, Malago, M, Bockisch, A, Kuehl, H, Li, J & Broelsch, CE 2010, 'The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors', ANN SURG, vol. 252, no. 5, 5, pp. 850-856. https://doi.org/10.1097/SLA.0b013e3181fd37e8

APA

Frilling, A., Sotiropoulos, G. C., Radtke, A., Malago, M., Bockisch, A., Kuehl, H., Li, J., & Broelsch, C. E. (2010). The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. ANN SURG, 252(5), 850-856. [5]. https://doi.org/10.1097/SLA.0b013e3181fd37e8

Vancouver

Frilling A, Sotiropoulos GC, Radtke A, Malago M, Bockisch A, Kuehl H et al. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. ANN SURG. 2010 Nov;252(5):850-856. 5. https://doi.org/10.1097/SLA.0b013e3181fd37e8

Bibtex

@article{72c26f43a99b47f0ad7c821f12288d5a,
title = "The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors",
abstract = "To evaluate the impact of 68Ga-DOTATOC positron emission tomography (PET)/computed tomography (CT) on the multimodal management of neuroendocrine tumors (NET).",
keywords = "Adult, Humans, Male, Aged, Female, Middle Aged, Sensitivity and Specificity, Disease Progression, Magnetic Resonance Imaging, Neoplasm Staging, Whole Body Imaging, Tomography, X-Ray Computed/*methods, Positron-Emission Tomography/*methods, Radiopharmaceuticals/*diagnostic use, Gallium Radioisotopes, Neuroendocrine Tumors/pathology/*radiography/*radionuclide imaging, Octreotide/*analogs & derivatives/diagnostic use, Adult, Humans, Male, Aged, Female, Middle Aged, Sensitivity and Specificity, Disease Progression, Magnetic Resonance Imaging, Neoplasm Staging, Whole Body Imaging, Tomography, X-Ray Computed/*methods, Positron-Emission Tomography/*methods, Radiopharmaceuticals/*diagnostic use, Gallium Radioisotopes, Neuroendocrine Tumors/pathology/*radiography/*radionuclide imaging, Octreotide/*analogs & derivatives/diagnostic use",
author = "Andrea Frilling and Sotiropoulos, {Georgios C} and Arnold Radtke and Massimo Malago and Andreas Bockisch and Hilmar Kuehl and Jun Li and Broelsch, {Christoph E}",
year = "2010",
month = nov,
doi = "10.1097/SLA.0b013e3181fd37e8",
language = "English",
volume = "252",
pages = "850--856",
journal = "ANN SURG",
issn = "0003-4932",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

RIS

TY - JOUR

T1 - The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors

AU - Frilling, Andrea

AU - Sotiropoulos, Georgios C

AU - Radtke, Arnold

AU - Malago, Massimo

AU - Bockisch, Andreas

AU - Kuehl, Hilmar

AU - Li, Jun

AU - Broelsch, Christoph E

PY - 2010/11

Y1 - 2010/11

N2 - To evaluate the impact of 68Ga-DOTATOC positron emission tomography (PET)/computed tomography (CT) on the multimodal management of neuroendocrine tumors (NET).

AB - To evaluate the impact of 68Ga-DOTATOC positron emission tomography (PET)/computed tomography (CT) on the multimodal management of neuroendocrine tumors (NET).

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Sensitivity and Specificity

KW - Disease Progression

KW - Magnetic Resonance Imaging

KW - Neoplasm Staging

KW - Whole Body Imaging

KW - Tomography, X-Ray Computed/methods

KW - Positron-Emission Tomography/methods

KW - Radiopharmaceuticals/diagnostic use

KW - Gallium Radioisotopes

KW - Neuroendocrine Tumors/pathology/radiography/radionuclide imaging

KW - Octreotide/analogs & derivatives/diagnostic use

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Female

KW - Middle Aged

KW - Sensitivity and Specificity

KW - Disease Progression

KW - Magnetic Resonance Imaging

KW - Neoplasm Staging

KW - Whole Body Imaging

KW - Tomography, X-Ray Computed/methods

KW - Positron-Emission Tomography/methods

KW - Radiopharmaceuticals/diagnostic use

KW - Gallium Radioisotopes

KW - Neuroendocrine Tumors/pathology/radiography/radionuclide imaging

KW - Octreotide/analogs & derivatives/diagnostic use

U2 - 10.1097/SLA.0b013e3181fd37e8

DO - 10.1097/SLA.0b013e3181fd37e8

M3 - SCORING: Journal article

C2 - 21037441

VL - 252

SP - 850

EP - 856

JO - ANN SURG

JF - ANN SURG

SN - 0003-4932

IS - 5

M1 - 5

ER -